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Association analysis of IL19, IL20 and 
IL24 genes in palmoplantar pustulosis
Up to 24% of patients with palmoplantar pustulosis (PPP) 
concomitantly have plaque-type psoriasis; however, no 
common genetic factors have been identified so far. Kingo 
et al. have studied the genes encoding the interleukin (IL)-
19 subfamily of cytokines (IL-19, IL-20 and IL-24), the 
members of which have recently been discovered as impor-
tant mediators in the pathophysiology of psoriasis, as possi-
ble genetic risk factors for PPP. They found that an extended 
IL19/IL20 haplotype was associated with an increased sus-
ceptibility to PPP while carriers of an extended IL20/IL24 
haplotype appeared to have a smaller risk for PPP. A similar 
constellation has previously been established in patients 
with plaque-type psoriasis compared with healthy indi-
viduals. It seems possible that the IL19 gene cluster repre-
sents a susceptibility region shared by PPP and plaque-type 
psoriasis, and is a part of the genetic basis underlying the 
frequent coexistence of PPP and plaque-type psoriasis. Br J 
Dermatol 2007; 156:646–652.
Early increase in serum levels of the 
angiogenesis-inhibitor endostatin 
and of basic fibroblast growth factor 
in melanoma patients during disease 
progression
Effective therapeutic options are still not available for 
advanced-stage melanoma. Early detection of primary 
tumours and of limited locoregional metastases is the best 
way to decrease mortality. A tumour marker indicating early 
metastatic spread would be of great value. The melanoma 
marker S-100 B is frequently elevated in patients with 
organ metastases, but usually fails to indicate lymph node 
metastases. Kurschat et al. show that the angiogenesis-
related factors basic fibroblast growth factor and endostatin 
are elevated in a substantial number of patients with stage 
III disease. Although not specific for melanoma, they might 
be valuable in the follow-up of patients with melanoma. 
Br J Dermatol 2007; 156:653–658.
To freeze or not to freeze: a cost-
effectiveness analysis of wart 
treatment
The cost-effectiveness 
of treating cutaneous 
(nongenital) warts is 
questionable. The cost-
effectiveness of treat-
ments was assessed 
using a decision ana-
lytic Markov model 
based on systematic 
review evidence. Results suggest that salicylic acid (SA) is 
the most cost-effective over-the-counter treatment examined 
in the model and that it is more cost-effective for general 
practitioners to prescribe SA than to administer cryotherapy. 
Nurse-administered cryotherapy is a potentially cost-effec-
tive alternative to general practitioner-administered cryother-
apy, but if rigorous trials verify the effectiveness estimates of 
duct tape occlusion therapy, its use as the primary treatment 
for cutaneous warts could be more cost-effective than either 
over-the-counter SA or nurse-administered cryotherapy. Br J 
Dermatol 2007; 156:687–692.
Early allergen exposure and atopic 
eczema
Harris et al. investigated the role of aeroallergens in causing 
eczema in a British birth cohort study. They did not find any 
linear associations between early exposure to house dust 
mite or cat allergen and subsequent risk of eczema, and 
found a nonsignificant decrease in eczema risk at the high-
est levels of allergen at birth. This lack of any clear expo-
sure–disease relationship argues against allergen exposure 
as being a major factor causing eczema. Interventions 
aimed at reducing house dust mite in early infancy could 
paradoxically increase the risk of subsequent eczema. Br J 
Dermatol 2007; 156:698–704.
